Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Growth Metrics

Others

Marimed (MRMD) Long-Term Deferred Tax (2019 - 2020)

Marimed (MRMD) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $57.9 million as the latest value for Q4 2020.

On a quarterly basis, Long-Term Deferred Tax fell 16.02% to $57.9 million in Q4 2020 year-over-year; TTM through Dec 2020 was $57.9 million, a 16.02% decrease, with the full-year FY2020 number at $57.9 million, down 16.02% from a year prior.
Long-Term Deferred Tax was $57.9 million for Q4 2020 at Marimed, down from $68.9 million in the prior quarter.
In the past five years, Long-Term Deferred Tax ranged from a high of $68.9 million in Q4 2019 to a low of $57.9 million in Q4 2020.